November 13, 2019

Please reload

Recent Posts

hemotune is awarded 0.5 million euros by EIT Health

July 9, 2020

1/6
Please reload

Featured Posts

hemotune featured in BioChip review

March 27, 2020

 

In his interesting review, Joo H. Kang (BioChip Journal, 2020) writes about ingenious approaches that address the unmet needs in sepsis treatment. He explicitly mentions hemotune performing pioneer work in the field of magnetic nanoparticle assisted blood cleansing devices. According to Kang, this revolutionary technology bears great potential for the successful removal of toxic molecules in a patient’s blood stream. This could have a significant positive impact on the outcome of sepsis and additionally, reduce the mortality rate (1).

 

Sepsis is a dysregulated immune response to infection with globally 11 million deaths annually. Its most severe form septic shock has mortality rates of 30-50%. hemotune’s treatment is designed to restore adequate immune function in septic shock patients and to improve their outcomes. Read more about our technology here.

 

 

 

(1) Kang JH. Multiscale Biofluidic and Nanobiotechnology Approaches forTreating Sepsis in Extracorporeal Circuits. BioChip J. 2020. doi:10.1007/s13206-020-4106-6

 

 

 

 

Share on Facebook
Share on Twitter
Please reload

Follow Us
Please reload

Search By Tags